Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesNon-Current ReceivablesReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Braskem (BAK) Shares Outstanding (2017 - 2025)

Braskem has reported Shares Outstanding over the past 9 years, most recently at $83.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 7.79% year-over-year to $83.8 million; the TTM value through Dec 2025 reached $83.8 million, up 7.79%, while the annual FY2025 figure was $83.8 million, 7.79% up from the prior year.
  • Shares Outstanding for Q4 2025 was $83.8 million at Braskem, up from $77.7 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $91.2 million in Q4 2023 and troughed at $77.7 million in Q4 2024.
  • A 5-year average of $83.9 million and a median of $83.8 million in 2025 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: dropped 14.81% in 2024 and later grew 7.79% in 2025.
  • Year by year, Shares Outstanding stood at $81.0 million in 2021, then grew by 6.03% to $85.9 million in 2022, then increased by 6.27% to $91.2 million in 2023, then dropped by 14.81% to $77.7 million in 2024, then increased by 7.79% to $83.8 million in 2025.
  • Business Quant data shows Shares Outstanding for BAK at $83.8 million in Q4 2025, $77.7 million in Q4 2024, and $91.2 million in Q4 2023.